Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Accumulated Expenses (2017 - 2025)

Inspire Medical Systems' Accumulated Expenses history spans 9 years, with the latest figure at $59.5 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 19.42% year-over-year to $59.5 million; the TTM value through Dec 2025 reached $59.5 million, up 19.42%, while the annual FY2025 figure was $59.5 million, 19.42% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $59.5 million at Inspire Medical Systems, up from $51.6 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $59.5 million in Q4 2025 and bottomed at $10.4 million in Q1 2021.
  • The 5-year median for Accumulated Expenses is $29.5 million (2022), against an average of $30.6 million.
  • The largest YoY upside for Accumulated Expenses was 68.32% in 2023 against a maximum downside of 3.37% in 2023.
  • A 5-year view of Accumulated Expenses shows it stood at $20.5 million in 2021, then soared by 67.88% to $34.3 million in 2022, then increased by 14.35% to $39.3 million in 2023, then increased by 26.86% to $49.8 million in 2024, then increased by 19.42% to $59.5 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Accumulated Expenses are $59.5 million (Q4 2025), $51.6 million (Q3 2025), and $40.2 million (Q2 2025).